Ryan Gerbrandt - Jan 16, 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Chief Operating Officer
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Jan 16, 2025
Transactions value $
$0
Form type
4
Date filed
1/21/2025, 05:24 PM
Previous filing
Oct 8, 2024
Next filing
May 20, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +67.8K $0.00 67.8K Jan 16, 2025 Common Stock 67.8K $27.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.